Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.400
+0.120 (9.38%)
Nov 20, 2024, 4:00 PM EST - Market closed
Apyx Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -28.44 | -18.71 | -23.18 | -15.17 | -11.9 | -19.71 | Upgrade
|
Depreciation & Amortization | 0.61 | 0.69 | 0.89 | 0.9 | 0.89 | 0.75 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.17 | -2.53 | 0.08 | 0.05 | 0.01 | 0.09 | Upgrade
|
Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.16 | Upgrade
|
Stock-Based Compensation | 4.09 | 5.11 | 6.7 | 5.09 | 4.21 | 3.58 | Upgrade
|
Provision & Write-off of Bad Debts | 0.25 | 0.28 | 0.32 | 0.13 | 0.26 | -0.16 | Upgrade
|
Other Operating Activities | 4.6 | 4.37 | 0.14 | 0.4 | 0.71 | 0.45 | Upgrade
|
Change in Accounts Receivable | -0.5 | -3.57 | 1.92 | -4.9 | -0.56 | -3.97 | Upgrade
|
Change in Inventory | 1.96 | 1.46 | -5.57 | -2.86 | 0.62 | -2.37 | Upgrade
|
Change in Accounts Payable | -0.18 | 0.03 | 0.07 | 1.15 | -0.97 | 1.05 | Upgrade
|
Change in Income Taxes | - | 7.55 | 0.1 | 0.01 | -7.23 | 0.18 | Upgrade
|
Change in Other Net Operating Assets | 0.13 | 0.09 | -1.73 | 4.75 | -2.12 | 1.78 | Upgrade
|
Operating Cash Flow | -17.32 | -5.25 | -20.28 | -10.45 | -16.07 | -18.48 | Upgrade
|
Capital Expenditures | -0.57 | -0.53 | -1.01 | -0.72 | -0.58 | -1.3 | Upgrade
|
Sale of Property, Plant & Equipment | - | 7.27 | - | - | - | - | Upgrade
|
Investment in Securities | - | - | - | - | - | 61.84 | Upgrade
|
Investing Cash Flow | -0.57 | 6.73 | -1.01 | -0.72 | -0.58 | 60.54 | Upgrade
|
Long-Term Debt Issued | - | 43.47 | - | - | - | - | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -0.14 | - | Upgrade
|
Long-Term Debt Repaid | - | -11.07 | -0.15 | -0.24 | -0.23 | -0.06 | Upgrade
|
Total Debt Repaid | -11.05 | -11.07 | -0.15 | -0.24 | -0.37 | -0.06 | Upgrade
|
Net Debt Issued (Repaid) | 23.14 | 32.41 | -0.15 | -0.24 | -0.37 | -0.06 | Upgrade
|
Issuance of Common Stock | - | 0.09 | 0.37 | 0.07 | 0.15 | 0.21 | Upgrade
|
Other Financing Activities | 0.69 | -0.33 | - | 0.2 | 0.15 | - | Upgrade
|
Financing Cash Flow | 23.83 | 32.17 | 0.22 | 0.02 | -0.07 | 0.15 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.06 | -0.19 | 0.4 | 0.1 | -0.18 | 0 | Upgrade
|
Net Cash Flow | 5.88 | 33.46 | -20.68 | -11.05 | -16.9 | 42.22 | Upgrade
|
Free Cash Flow | -17.89 | -5.78 | -21.29 | -11.17 | -16.65 | -19.78 | Upgrade
|
Free Cash Flow Margin | -36.86% | -11.05% | -47.83% | -23.03% | -60.07% | -70.04% | Upgrade
|
Free Cash Flow Per Share | -0.52 | -0.17 | -0.62 | -0.33 | -0.49 | -0.58 | Upgrade
|
Cash Interest Paid | 5.22 | 2.48 | 0.02 | 0.01 | 0.05 | 0.01 | Upgrade
|
Cash Income Tax Paid | 0.28 | 0.33 | 0.13 | 0.11 | 0.08 | 0.33 | Upgrade
|
Levered Free Cash Flow | -4.33 | 3.37 | -5.54 | -5.33 | -17.36 | -12.53 | Upgrade
|
Unlevered Free Cash Flow | -0.97 | 4.92 | -5.53 | -5.33 | -17.33 | -12.52 | Upgrade
|
Change in Net Working Capital | -3.11 | -6.85 | 4.23 | 1.56 | 9.3 | 3.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.